Health Care

The drugmaker's quarterly revenue fell far less than expected as plunging sales of its depression treatment were offset by higher sales of other drugs.

Bristol-Myers Squibb reported a 21% drop in its fourth-quarter profit, a year after the drug company logged a significant tax benefit.

Quest Diagnostics agreed to pay a private equity firm $570 million for Solstas Lab Partners Group, as the testing provider continues to expand its laboratory offerings.

Johnson & Johnson posted profits of $1.24 per share on revenues of $18.4 billion, beating on both lines in the fourth quarter. 

UnitedHealth, the nation's largest health insurer, said its fourth-quarter profit rose 15% amid higher enrollments and strong results from its health services business.

Aetna raised its revenue view for 2014 by $1 billion, as Medicare membership gains topped the health insurance provider’s expectations.

McKesson didn’t receive the required shareholder support in its attempt to purchase German drug and pharmacy giant Celesio, less than a week after boosting its offer.

Facing an imminent deadline to complete the deal, McKesson agreed to increase its $8.3 billion buyout offer of German drug distributor Celesio.

Pharmaceutical company Forest Labs inked a $2.9 billion all-cash deal to acquire privately held drug maker Aptalis.

The drugmaker said its commitments to preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca were legally binding.

Today’s stock suggestion is biopharmaceutical company Medivation.

Middle-market dealmakers say the pace of growth in overall deal flow increased again in July.

After a brief hiatus in April and May, U.S. IPOs are making a comeback, with this week set to be the biggest since 2006, according to Renaissance Capital data.

Merck agreed to sell Asian rights to its eye treatment products business to Japan’s Santen Pharmaceutical for $600 million. 

The Botox maker turned down an unsolicited $46 billion bid from Valeant Pharmaceuticals, which vowed to continue its pursuit of a deal.

CVS Health and Target ink deal for CVS to acquire Target's pharmacy and clinic businesses for about $1.9 billion.

Many athletes follow a pretty standard routine. Hit the gym, grab a protein shake, repeat. Others, like surfer Laird Hamilton, take fitness to another level. Hamilton and fitness expert Mike Barwis share some of their secrets.

As the biotech index soars to historic highs, industry investors are seeing gains of 50% in the past year. But while some investors are cashing in on medical breakthroughs, others are issuing a warning. Will we continue to see robust sector growth or will this boom come down crashing?

Once you reach that golden age of 65 Medicare steps in to take care of most of your healthcare needs.  But there are a lot of exclusions with Medicare plans and for Baby Boomers living on a fixed income, those exclusions along with the out of pocket expenses can have a huge impact on your financial future.

Wired medicine is becoming the way of the world as more doctors and pharmacists treat patients using the power of the internet.